Recon: Medical societies sue HHS over vaccine policy; FDA approves KalVista’s swelling disorder drug
ReconMichael Mezher
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States